CX3CL1 and diabetic retinopathy: Studies of CX3CR1-KO and CX3CL1-KO mice reveal that a disrupted CX3CR1/CX3CL1 signaling pathway exacerbates diabetic retinopathy damage through microglial activation, neuronal cell loss, and vascular impairment.